Y Intercept Hong Kong Ltd Increases Stake in Universal Health Services, Inc. (NYSE:UHS)

Y Intercept Hong Kong Ltd grew its position in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 73.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,374 shares of the health services provider's stock after purchasing an additional 8,176 shares during the period. Y Intercept Hong Kong Ltd's holdings in Universal Health Services were worth $3,476,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in UHS. Los Angeles Capital Management LLC raised its position in Universal Health Services by 102.0% in the third quarter. Los Angeles Capital Management LLC now owns 210,926 shares of the health services provider's stock worth $48,304,000 after acquiring an additional 106,517 shares during the period. AustralianSuper Pty Ltd bought a new stake in Universal Health Services in the fourth quarter worth about $18,709,000. Mizuho Securities USA LLC raised its position in Universal Health Services by 2,101.2% in the third quarter. Mizuho Securities USA LLC now owns 101,188 shares of the health services provider's stock worth $23,173,000 after acquiring an additional 96,591 shares during the period. World Investment Advisors LLC bought a new stake in Universal Health Services in the third quarter worth about $21,557,000. Finally, Worldquant Millennium Advisors LLC raised its position in Universal Health Services by 70.8% in the third quarter. Worldquant Millennium Advisors LLC now owns 214,379 shares of the health services provider's stock worth $49,095,000 after acquiring an additional 88,872 shares during the period. Hedge funds and other institutional investors own 86.05% of the company's stock.

Insiders Place Their Bets

In other news, Director Maria Ruderman Singer sold 1,614 shares of the company's stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $191.15, for a total value of $308,516.10. Following the sale, the director now directly owns 5,879 shares of the company's stock, valued at $1,123,770.85. This represents a 21.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 16.10% of the company's stock.

Analyst Ratings Changes

UHS has been the topic of several research reports. TD Cowen lowered their price objective on shares of Universal Health Services from $275.00 to $251.00 and set a "buy" rating on the stock in a research report on Tuesday, November 26th. Bank of America started coverage on shares of Universal Health Services in a research report on Wednesday, November 6th. They issued a "neutral" rating and a $223.00 price objective on the stock. Barclays lowered their price target on shares of Universal Health Services from $271.00 to $249.00 and set an "overweight" rating on the stock in a research report on Thursday. Wells Fargo & Company lowered their price target on shares of Universal Health Services from $285.00 to $230.00 and set an "overweight" rating on the stock in a research report on Monday, November 25th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and issued a $226.00 price target on shares of Universal Health Services in a research report on Tuesday, December 17th. Six analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Universal Health Services currently has an average rating of "Moderate Buy" and a consensus target price of $225.29.

Universal Health Services Trading Up 2.9 %

Shares of Universal Health Services stock traded up $5.14 during trading on Thursday, reaching $185.26. The company's stock had a trading volume of 2,144,716 shares, compared to its average volume of 599,166. Universal Health Services, Inc. has a 52-week low of $152.68 and a 52-week high of $243.25. The company has a market cap of $12.22 billion, a price-to-earnings ratio of 12.32, a PEG ratio of 0.53 and a beta of 1.30. The firm's 50-day moving average is $184.38 and its two-hundred day moving average is $205.46. The company has a quick ratio of 1.28, a current ratio of 1.39 and a debt-to-equity ratio of 0.69.

Universal Health Services (NYSE:UHS - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported $4.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.21 by $0.71. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. The company had revenue of $4.11 billion during the quarter, compared to analysts' expectations of $4.01 billion. On average, sell-side analysts anticipate that Universal Health Services, Inc. will post 15.92 earnings per share for the current year.

Universal Health Services Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be issued a $0.20 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.80 annualized dividend and a yield of 0.43%. Universal Health Services's dividend payout ratio (DPR) is presently 5.32%.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.